Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

The predictive value of early assessment after one cycle of induction chemotherapy with 18F-FDG-PET/CT and DW-MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma

Kee Howe Wong, Rafal Panek, Liam C Welsh, Dualta Mcquaid, Alex Dunlop, Angela Riddell, Iain Murray, Yong Du, Sue Chua, Dow-Mu Koh, Shreerang Bhide, Christopher M Nutting, Wim J. G. Oyen, Kevin J Harrington and Kate L Newbold
Journal of Nuclear Medicine July 2016, jnumed.116.174433; DOI: https://doi.org/10.2967/jnumed.116.174433
Kee Howe Wong
1 The Institute of Cancer Research, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafal Panek
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liam C Welsh
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dualta Mcquaid
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Dunlop
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Riddell
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain Murray
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Du
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sue Chua
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dow-Mu Koh
1 The Institute of Cancer Research, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shreerang Bhide
1 The Institute of Cancer Research, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M Nutting
2 The Royal Marsden NHS foundation trust, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim J. G. Oyen
1 The Institute of Cancer Research, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin J Harrington
1 The Institute of Cancer Research, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate L Newbold
3 The Royal Marsden NHS Foundation Trust, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.116.174433
DOI 
https://doi.org/10.2967/jnumed.116.174433
PubMed 
27417648

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online July 14, 2016.

Article Versions

  • You are currently viewing a previous version of this article (July 14, 2016 - 06:39).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Kee Howe Wong1,
  2. Rafal Panek2,
  3. Liam C Welsh2,
  4. Dualta Mcquaid2,
  5. Alex Dunlop2,
  6. Angela Riddell2,
  7. Iain Murray2,
  8. Yong Du2,
  9. Sue Chua2,
  10. Dow-Mu Koh1,
  11. Shreerang Bhide1,
  12. Christopher M Nutting2,
  13. Wim J. G. Oyen1,
  14. Kevin J Harrington1 and
  15. Kate L Newbold3
  1. 1 The Institute of Cancer Research, United Kingdom;
  2. 2 The Royal Marsden NHS foundation trust, United Kingdom;
  3. 3 The Royal Marsden NHS Foundation Trust, United Kingdom
  1. For correspondence or reprints contact: Kee Howe Wong, The Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, United Kingdom. E-mail: kee.wong@icr.ac.uk

Statistics from Altmetric.com

Cited By...

  • 45 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • State of the art MRI in head and neck cancer
    Y.L. Dai, A.D. King
    Clinical Radiology 2018 73 1
  • Imaging biomarkers in oncology: Basics and application to MRI
    Isabel Dregely, Davide Prezzi, Christian Kelly‐Morland, Elisa Roccia, Radhouene Neji, Vicky Goh
    Journal of Magnetic Resonance Imaging 2018 48 1
  • Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation
    Roland M. Martens, Thomas Koopman, Cristina Lavini, Meedie Ali, Carel F. W. Peeters, Daniel P. Noij, Gerben Zwezerijnen, J. Tim Marcus, Marije R. Vergeer, C. René Leemans, Remco de Bree, Pim de Graaf, Ronald Boellaard, Jonas A. Castelijns
    European Radiology 2021 31 2
  • Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer
    Jia Wu, Michael F. Gensheimer, Nasha Zhang, Meiying Guo, Rachel Liang, Carrie Zhang, Nancy Fischbein, Erqi L. Pollom, Beth Beadle, Quynh-Thu Le, Ruijiang Li
    Journal of Nuclear Medicine 2020 61 3
  • The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective
    Kee H Wong, Rafal Panek, Shreerang A Bhide, Christopher M Nutting, Kevin J Harrington, Katie L Newbold
    The British Journal of Radiology 2017 90 1071
  • Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Sae Rom Chung, Young Jun Choi, Chong Hyun Suh, Jeong Hyun Lee, Jung Hwan Baek
    Korean Journal of Radiology 2019 20 4
  • Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer
    Kee H. Wong, Rafal Panek, Alex Dunlop, Dualta Mcquaid, Angela Riddell, Liam C. Welsh, Iain Murray, Dow-Mu Koh, Martin O. Leach, Shreerang A. Bhide, Christopher M. Nutting, Wim J. Oyen, Kevin J. Harrington, Kate L. Newbold
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 5
  • Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment 18F-PET/CT
    Zheran Liu, Yuan Cao, Wei Diao, Yue Cheng, Zhiyun Jia, Xingchen Peng
    Aging 2020 12 14
  • Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?
    I. Petkar, S. Bhide, K. Newbold, K. Harrington, C. Nutting
    Clinical Oncology 2017 29 7
  • Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma
    Yu-Hung Chen, Kai-Ping Chang, Sung-Chao Chu, Tzu-Chen Yen, Ling-Yi Wang, Joseph Tung-Chieh Chang, Cheng-Lung Hsu, Shu-Hang Ng, Shu-Hsin Liu, Sheng-Chieh Chan
    European Journal of Nuclear Medicine and Molecular Imaging 2019 46 3

Article usage

Article usage: July 2016 to April 2025

AbstractFullPdf
Jul 2016316245
Aug 2016144243
Sep 2016234131
Oct 2016416034
Nov 2016251011
Dec 2016171231103
Jan 20176472546
Feb 2017383819
Mar 20172841020
Apr 2017233911
May 20171051012
Jun 2017921821
Jul 2017982529
Aug 201750724
Sep 2017521210
Oct 2017561616
Nov 2017522231
Dec 2017772022
Jan 2018652319
Feb 2018422216
Mar 2018541431
Apr 201853626
May 201842817
Jun 201839510
Jul 2018331015
Aug 20182865
Sep 201828720
Oct 2018311421
Nov 2018381425
Dec 2018201433
Jan 201930722
Feb 201916139
Mar 20192666
Apr 201919511
May 201935149
Jun 20192134
Jul 2019231112
Aug 2019251714
Sep 20193258
Oct 2019181310
Nov 20193497
Dec 201928714
Jan 20202499
Feb 20201464
Mar 2020161214
Apr 202015712
May 2020171217
Jun 202023511
Jul 20201865
Aug 20201355
Sep 20203458
Oct 20202273
Nov 2020321516
Dec 202026198
Jan 2021410732
Feb 202182125
Mar 202112196
Apr 20216446
May 202116449
Jun 2021123818
Jul 2021133228
Aug 2021172423
Sep 202192225
Oct 202182031
Nov 2021142118
Dec 2021132710
Jan 2022112913
Feb 202212232
Mar 2022162410
Apr 202211239
May 202294517
Jun 20227398
Jul 2022116311
Aug 20229496
Sep 2022103817
Oct 2022162810
Nov 20227298
Dec 20224173
Jan 20237425
Feb 2023142910
Mar 20236568
Apr 202331913
May 202382312
Jun 20232106
Jul 20235912
Aug 202361311
Sep 2023463
Oct 202351712
Nov 202314368
Dec 20239705
Jan 202411205
Feb 20244139
Mar 202471543
Apr 202472618
May 202433019
Jun 202481916
Jul 202481922
Aug 20242269
Sep 202441813
Oct 202462216
Nov 202473317
Dec 202452813
Jan 202551222
Feb 202514936
Mar 202555317
Apr 202585054
Next
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The predictive value of early assessment after one cycle of induction chemotherapy with 18F-FDG-PET/CT and DW-MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The predictive value of early assessment after one cycle of induction chemotherapy with 18F-FDG-PET/CT and DW-MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma
Kee Howe Wong, Rafal Panek, Liam C Welsh, Dualta Mcquaid, Alex Dunlop, Angela Riddell, Iain Murray, Yong Du, Sue Chua, Dow-Mu Koh, Shreerang Bhide, Christopher M Nutting, Wim J. G. Oyen, Kevin J Harrington, Kate L Newbold
Journal of Nuclear Medicine Jul 2016, jnumed.116.174433; DOI: 10.2967/jnumed.116.174433

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The predictive value of early assessment after one cycle of induction chemotherapy with 18F-FDG-PET/CT and DW-MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma
Kee Howe Wong, Rafal Panek, Liam C Welsh, Dualta Mcquaid, Alex Dunlop, Angela Riddell, Iain Murray, Yong Du, Sue Chua, Dow-Mu Koh, Shreerang Bhide, Christopher M Nutting, Wim J. G. Oyen, Kevin J Harrington, Kate L Newbold
Journal of Nuclear Medicine Jul 2016, jnumed.116.174433; DOI: 10.2967/jnumed.116.174433
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Diffusion-Weighted Imaging to Assess HPV-Positive versus HPV-Negative Oropharyngeal Squamous Cell Carcinoma: The Importance of b-Values
  • Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
  • Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Oncology: Head and Neck)

  • The Added Value of 68Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with 18F-FDG–Negative Findings
Show more Clinical (Oncology: Head and Neck)

Similar Articles

Keywords

  • MRI
  • oncology: head and neck
  • PET/CT
  • radiation therapy planning
  • 18F-FDG-PET/CT
  • Diffusion-weighted MRI
  • induction chemotherapy
  • head and neck squamous cell carcinoma
SNMMI

© 2025 SNMMI

Powered by HighWire